Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ronald Geoffrey Marcus, M.B.,B.Ch.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Nelson JC, Thase ME, Bellocchio EE, Rollin LM, Eudicone JM, McQuade RD, Marcus RN, Berman RM, Baker RA. Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy. Int Clin Psychopharmacol. 2012 May; 27(3):125-33. PMID: 22466058.
    Citations: 8     Fields:    Translation:Humans
  2. Varni JW, Handen BL, Corey-Lisle PK, Guo Z, Manos G, Ammerman DK, Marcus RN, Owen R, McQuade RD, Carson WH, Mathew S, Mankoski R. Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials. Clin Ther. 2012 Apr; 34(4):980-92. PMID: 22444782.
    Citations: 14     Fields:    Translation:Humans
  3. Carlson BX, Ketter TA, Sun W, Timko K, McQuade RD, Sanchez R, Vester-Blokland E, Marcus R. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). Bipolar Disord. 2012 Feb; 14(1):41-53. PMID: 22329471.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  4. Thase ME, Bowden CL, Nashat M, Eudicone JM, Marcus R, McQuade RD, Carlson BX. Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms. Int J Psychiatry Clin Pract. 2012 Jun; 16(2):121-31. PMID: 22296512.
    Citations: 6     Fields:    Translation:Humans
  5. El-Mallakh RS, Marcus R, Baudelet C, McQuade R, Carson WH, Owen R. A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder. J Affect Disord. 2012 Feb; 136(3):258-66. PMID: 22209190.
    Citations: 5     Fields:    Translation:Humans
  6. Marcus RN, Owen R, Manos G, Mankoski R, Kamen L, McQuade RD, Carson WH, Findling RL. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study. J Clin Psychiatry. 2011 Sep; 72(9):1270-6. PMID: 21813076.
    Citations: 19     Fields:    Translation:HumansCTClinical Trials
  7. Marcus RN, Owen R, Manos G, Mankoski R, Kamen L, McQuade RD, Carson WH, Corey-Lisle PK, Aman MG. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study. J Child Adolesc Psychopharmacol. 2011 Jun; 21(3):229-36. PMID: 21663425.
    Citations: 22     Fields:    Translation:HumansCTClinical Trials
  8. Berman RM, Thase ME, Trivedi MH, Hazel JA, Marler SV, McQuade RD, Carson W, Baker RA, Marcus RN. Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder. Neuropsychiatr Dis Treat. 2011; 7:303-12. PMID: 21655344.
    Citations: 12     
  9. Marcus R, Khan A, Rollin L, Morris B, Timko K, Carson W, Sanchez R. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Bipolar Disord. 2011 Mar; 13(2):133-44. PMID: 21443567.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  10. Robb AS, Andersson C, Bellocchio EE, Manos G, Rojas-Fernandez C, Mathew S, Marcus R, Owen R, Mankoski R. Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies. Prim Care Companion CNS Disord. 2011; 13(1). PMID: 21731831.
    Citations: 13     Fields:    
  11. Aman MG, Kasper W, Manos G, Mathew S, Marcus R, Owen R, Mankoski R. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder. J Child Adolesc Psychopharmacol. 2010 Oct; 20(5):415-22. PMID: 20973712.
    Citations: 12     Fields:    Translation:Humans
  12. El Mallakh RS, Vieta E, Rollin L, Marcus R, Carson WH, McQuade R. A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007). Eur Neuropsychopharmacol. 2010 Nov; 20(11):776-83. PMID: 20728318.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  13. Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Curr Med Res Opin. 2010 Jun; 26(6):1485-96. PMID: 20429835.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  14. Reimherr FW, Martin ML, Eudicone JM, Marchant BK, Tran QV, Pikalov A, Marcus RN, Berman RM, Carlson BX. A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole. J Clin Psychopharmacol. 2010 Jun; 30(3):300-5. PMID: 20473067.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  15. Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, Carson WH, Findling RL. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009 Dec; 124(6):1533-40. PMID: 19948625.
    Citations: 125     Fields:    Translation:Humans
  16. Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, Aman MG. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009 Nov; 48(11):1110-1119. PMID: 19797985.
    Citations: 121     Fields:    Translation:Humans
  17. Fava M, Wisniewski SR, Thase ME, Baker RA, Tran QV, Pikalov A, Yang H, Marcus RN, Berman RM. Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies. J Clin Psychopharmacol. 2009 Aug; 29(4):362-7. PMID: 19593176.
    Citations: 6     Fields:    Translation:Humans
  18. Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, Carson WH, Adson D, Taylor L, Hazel J, Marcus RN. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. CNS Spectr. 2009 Apr; 14(4):197-206. PMID: 19407731.
    Citations: 57     Fields:    Translation:Humans
  19. Glick ID, Mankoski R, Eudicone JM, Marcus RN, Tran QV, Assunção-Talbott S. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials. J Affect Disord. 2009 May; 115(1-2):18-26. PMID: 19230981.
    Citations: 8     Fields:    Translation:Humans
  20. Coric V, Stock EG, Pultz J, Marcus R, Sheehan DV. Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety Disorder. Psychiatry (Edgmont). 2009 Jan; 6(1):26-31. PMID: 19724740.
    Citations: 22     
  21. Young AH, Oren DA, Lowy A, McQuade RD, Marcus RN, Carson WH, Spiller NH, Torbeyns AF, Sanchez R. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. Br J Psychiatry. 2009 Jan; 194(1):40-8. PMID: 19118324.
    Citations: 21     Fields:    Translation:Humans
  22. Nelson JC, Thase ME, Trivedi MH, Fava M, Han J, Van Tran Q, Pikalov A, Qi Y, Carlson BX, Marcus RN, Berman RM. Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163). Prim Care Companion J Clin Psychiatry. 2009; 11(6):344-52. PMID: 20098527.
    Citations: 7     
  23. Hanssens L, L'Italien G, Loze JY, Marcus RN, Pans M, Kerselaers W. The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC Psychiatry. 2008 Dec 22; 8:95. PMID: 19102734.
    Citations: 21     Fields:    Translation:Humans
  24. Janicak PG, Glick ID, Marder SR, Crandall DT, McQuade RD, Marcus RN, Eudicone JM, Assunção-Talbott S. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies. J Clin Psychiatry. 2009 Jan; 70(1):25-35. PMID: 19192472.
    Citations: 8     Fields:    Translation:Humans
  25. Trivedi MH, Thase ME, Fava M, Nelson CJ, Yang H, Qi Y, Tran QV, Pikalov A, Carlson BX, Marcus RN, Berman RM. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features. J Clin Psychiatry. 2008 Dec; 69(12):1928-36. PMID: 19192475.
    Citations: 17     Fields:    Translation:Humans
  26. Byerly MJ, Marcus RN, Tran QV, Eudicone JM, Whitehead R, Baker RA. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Schizophr Res. 2009 Feb; 107(2-3):218-22. PMID: 19038534.
    Citations: 19     Fields:    Translation:Humans
  27. Fleischhacker WW, McQuade RD, Marcus RN, Archibald D, Swanink R, Carson WH. A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia. Biol Psychiatry. 2009 Mar 15; 65(6):510-7. PMID: 18986646.
    Citations: 30     Fields:    Translation:Humans
  28. Newcomer JW, Meyer JM, Baker RA, Eudicone JM, Pikalov A, Vester-Blokland E, McQuade RD, Crandall DT, Carson WH, Marcus RN, L'italien G. Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine. Schizophr Res. 2008 Dec; 106(2-3):300-7. PMID: 18973991.
    Citations: 4     Fields:    Translation:Humans
  29. Rappaport SA, Marcus RN, Manos G, McQuade RD, Oren DA. A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia. J Am Med Dir Assoc. 2009 Jan; 10(1):21-7. PMID: 19111849.
    Citations: 9     Fields:    Translation:Humans
  30. Findling RL, Robb A, Nyilas M, Forbes RA, Jin N, Ivanova S, Marcus R, McQuade RD, Iwamoto T, Carson WH. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. Am J Psychiatry. 2008 Nov; 165(11):1432-41. PMID: 18765484.
    Citations: 65     Fields:    Translation:Humans
  31. Streim JE, Porsteinsson AP, Breder CD, Swanink R, Marcus R, McQuade R, Carson WH. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease. Am J Geriatr Psychiatry. 2008 Jul; 16(7):537-50. PMID: 18591574.
    Citations: 26     Fields:    Translation:Humans
  32. Newcomer JW, Campos JA, Marcus RN, Breder C, Berman RM, Kerselaers W, L'italien GJ, Nys M, Carson WH, McQuade RD. A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine. J Clin Psychiatry. 2008 Jul; 69(7):1046-56. PMID: 18605811.
    Citations: 34     Fields:    Translation:Humans
  33. Taylor D, Hanssens L, Loze JY, Pans M, L'Italien G, Marcus RN. Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: results from the STAR study. Eur Psychiatry. 2008 Aug; 23(5):336-43. PMID: 18423987.
    Citations: 6     Fields:    Translation:Humans
  34. Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava M, Simon JS, Trivedi MH, Thase ME, Berman RM. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol. 2008 Apr; 28(2):156-65. PMID: 18344725.
    Citations: 79     Fields:    Translation:Humans
  35. Frye MA, Eudicone J, Pikalov A, McQuade RD, Marcus RN, Carlson BX. Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials. J Clin Psychopharmacol. 2008 Apr; 28(2):243-5. PMID: 18344741.
    Citations: 2     Fields:    Translation:Humans
  36. Vieta E, T'joen C, McQuade RD, Carson WH, Marcus RN, Sanchez R, Owen R, Nameche L. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. Am J Psychiatry. 2008 Oct; 165(10):1316-25. PMID: 18381903.
    Citations: 22     Fields:    Translation:Humans
  37. Thase ME, Jonas A, Khan A, Bowden CL, Wu X, McQuade RD, Carson WH, Marcus RN, Owen R. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J Clin Psychopharmacol. 2008 Feb; 28(1):13-20. PMID: 18204335.
    Citations: 45     Fields:    Translation:Humans
  38. Anton RF, Kranzler H, Breder C, Marcus RN, Carson WH, Han J. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. J Clin Psychopharmacol. 2008 Feb; 28(1):5-12. PMID: 18204334.
    Citations: 27     Fields:    Translation:Humans
  39. Thase ME, Trivedi MH, Nelson JC, Fava M, Swanink R, Tran QV, Pikalov A, Yang H, Carlson BX, Marcus RN, Berman RM. Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies. Prim Care Companion J Clin Psychiatry. 2008; 10(6):440-7. PMID: 19287552.
    Citations: 14     
  40. Masand PS, Eudicone J, Pikalov A, McQuade RD, Marcus RN, Vester-Blokland E, Carlson BX. Criteria for defining symptomatic and sustained remission in bipolar I disorder: a post-hoc analysis of a 26-week aripiprazole study (study CN138-010). Psychopharmacol Bull. 2008; 41(2):12-23. PMID: 18668014.
    Citations: 3     Fields:    Translation:Humans
  41. Pratt SD, Mann S, Salisbury M, Greenberg P, Marcus R, Stabile B, McNamee P, Nielsen P, Sachs BP. John M. Eisenberg Patient Safety and Quality Awards. Impact of CRM-based training on obstetric outcomes and clinicians' patient safety attitudes. Jt Comm J Qual Patient Saf. 2007 Dec; 33(12):720-5. PMID: 18200896.
    Citations: 7     Fields:    Translation:Humans
  42. Mintzer JE, Tune LE, Breder CD, Swanink R, Marcus RN, McQuade RD, Forbes A. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. Am J Geriatr Psychiatry. 2007 Nov; 15(11):918-31. PMID: 17974864.
    Citations: 39     Fields:    Translation:Humans
  43. L'Italien GJ, Casey DE, Kan HJ, Carson WH, Marcus RN. Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo. J Clin Psychiatry. 2007 Oct; 68(10):1510-6. PMID: 17960964.
    Citations: 19     Fields:    Translation:Humans
  44. Keck PE, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, Carlson BX, Marcus RN, Sanchez R. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry. 2007 Oct; 68(10):1480-91. PMID: 17960961.
    Citations: 49     Fields:    Translation:HumansPHPublic Health
  45. Sachs GS, Gaulin BD, Gutierrez-Esteinou R, McQuade RD, Pikalov A, Pultz JA, Sanchez R, Marcus RN, Crandall DT. Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline. J Clin Psychiatry. 2007 Sep; 68(9):1377-83. PMID: 17915976.
    Citations: 8     Fields:    Translation:Humans
  46. Kane JM, Crandall DT, Marcus RN, Eudicone J, Pikalov A, Carson WH, Swyzen W. Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. Schizophr Res. 2007 Sep; 95(1-3):143-50. PMID: 17644313.
    Citations: 11     Fields:    Translation:Humans
  47. McEvoy JP, Daniel DG, Carson WH, McQuade RD, Marcus RN. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. J Psychiatr Res. 2007 Dec; 41(11):895-905. PMID: 17631314.
    Citations: 26     Fields:    Translation:Humans
  48. Berman RM, Marcus RN, Swanink R, McQuade RD, Carson WH, Corey-Lisle PK, Khan A. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Jun; 68(6):843-53. PMID: 17592907.
    Citations: 80     Fields:    Translation:Humans
  49. Marder SR, West B, Lau GS, Pultz JA, Pikalov A, Marcus RN, Gutierrez-Esteinou R, Crandall DT. Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials. J Clin Psychiatry. 2007 May; 68(5):662-8. PMID: 17503974.
    Citations: 4     Fields:    Translation:Humans
  50. Zimbroff DL, Marcus RN, Manos G, Stock E, McQuade RD, Auby P, Oren DA. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole. J Clin Psychopharmacol. 2007 Apr; 27(2):171-6. PMID: 17414241.
    Citations: 16     Fields:    Translation:Humans
  51. Kane JM, Meltzer HY, Carson WH, McQuade RD, Marcus RN, Sanchez R. Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine. J Clin Psychiatry. 2007 Feb; 68(2):213-23. PMID: 17335319.
    Citations: 22     Fields:    Translation:Humans
  52. Tran-Johnson TK, Sack DA, Marcus RN, Auby P, McQuade RD, Oren DA. Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2007 Jan; 68(1):111-9. PMID: 17284138.
    Citations: 20     Fields:    Translation:Humans
  53. Friedman JH, Berman RM, Goetz CG, Factor SA, Ondo WG, Wojcieszek J, Carson WH, Marcus RN. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Mov Disord. 2006 Dec; 21(12):2078-81. PMID: 17013906.
    Citations: 35     Fields:    Translation:Humans
  54. Chrzanowski WK, Marcus RN, Torbeyns A, Nyilas M, McQuade RD. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. Psychopharmacology (Berl). 2006 Dec; 189(2):259-66. PMID: 17058105.
    Citations: 36     Fields:    Translation:Humans
  55. Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology (Berl). 2006 Oct; 188(3):281-92. PMID: 16953381.
    Citations: 12     Fields:    Translation:Humans
  56. Mann S, Pratt S, Gluck P, Nielsen P, Risser D, Greenberg P, Marcus R, Goldman M, Shapiro D, Pearlman M, Sachs B. Assessing quality obstetrical care: development of standardized measures. Jt Comm J Qual Patient Saf. 2006 Sep; 32(9):497-505. PMID: 17987873.
    Citations: 28     Fields:    Translation:Humans
  57. Cutler AJ, Marcus RN, Hardy SA, O'Donnell A, Carson WH, McQuade RD. The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia. CNS Spectr. 2006 Sep; 11(9):691-702; quiz 719. PMID: 16946694.
    Citations: 13     Fields:    Translation:Humans
  58. Keck PE, Calabrese JR, McQuade RD, Carson WH, Carlson BX, Rollin LM, Marcus RN, Sanchez R. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry. 2006 Apr; 67(4):626-37. PMID: 16669728.
    Citations: 52     Fields:    Translation:HumansPHPublic Health
  59. Tandon R, Marcus RN, Stock EG, Riera LC, Kostic D, Pans M, McQuade RD, Nyilas M, Iwamoto T, Crandall DT. A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA). Schizophr Res. 2006 May; 84(1):77-89. PMID: 16483745.
    Citations: 29     Fields:    Translation:Humans
  60. Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, Abou-Gharbia N, Impellizzeri C, Kaplita S, Rollin L, Iwamoto T. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol. 2006 Jul; 20(4):536-46. PMID: 16401666.
    Citations: 44     Fields:    Translation:Humans
  61. Volavka J, Czobor P, Citrome L, McQuade RD, Carson WH, Kostic D, Hardy S, Marcus R. Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies. J Clin Psychiatry. 2005 Nov; 66(11):1362-6. PMID: 16420071.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  62. Tandon R, Devellis RF, Han J, Li H, Frangou S, Dursun S, Beuzen JN, Carson W, Corey-Lisle PK, Falissard B, Jody DN, Kujawa MJ, L'italien G, Marcus RN, McQuade RD, Ray S, Van Peborgh P. Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder. Psychiatry Res. 2005 Sep 15; 136(2-3):211-21. PMID: 16115690.
    Citations: 6     Fields:    Translation:Humans
  63. Vieta E, Bourin M, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, Abou-Gharbia N, Swanink R, Iwamoto T. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. Br J Psychiatry. 2005 Sep; 187:235-42. PMID: 16135860.
    Citations: 39     Fields:    Translation:Humans
  64. Kasper S, Lerman MN, McQuade RD, Saha A, Carson WH, Ali M, Archibald D, Ingenito G, Marcus R, Pigott T. Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. Int J Neuropsychopharmacol. 2003 Dec; 6(4):325-37. PMID: 14609439.
    Citations: 73     Fields:    Translation:HumansCTClinical Trials
  65. Keck PE, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, Ingenito G. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry. 2003 Sep; 160(9):1651-8. PMID: 12944341.
    Citations: 86     Fields:    Translation:HumansCTClinical Trials
  66. Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, Saha A, Ali M, Iwamoto T. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res. 2003 Jun 01; 61(2-3):123-36. PMID: 12729864.
    Citations: 84     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Marcus's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (176)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.